Castrejón RG, Obaldia CG, Rosas ZL, Hernández GS

Language: Spanish
References: 11
Page: 278-281
PDF size: 137.30 Kb.

ABSTRACT

Objective: To determine the perioperatory morbidity, recurrence and survival in a group of patients with prostatic cancer who were performed to radical prostatectomy in a period of six years in the Service of Surgical Oncology in the National Medical Center 20 de Noviembre, ISSSTE.
Patients and methods: From January of 2000 to March of 2005 all the files of all the patients who underwent radical prostatectomy on surgery stages were reviewed.
Results: There were 10 patients; the average length of follow-up was 19.6 months. The age average was 65.9 years. The value average of the preoperative PSA was 10.5 ng/dL. The value of the Gleason was 4 in 40% of the patients. All the histological types were adenocarcinomas; 80% in a clinical stage II. All resection lymphatic nodes were reported without metastases. Two patients were reported with positive surgical margin. Two patients presented recurrence of the disease, neither was related to positive margin. The average time of recurrence was of 28 months. The recurrence site went at bony and retroperitoneus level; 60% of the patients presented some complication, of which 30% were early complications, delayed 20% and early and delayed 10%. The actuarial global survival to 75 months is of 100%.
Conclusions: Rates of survival, morbidity and mortality, are similar to the reported ones in world-wide literature, being single elevated the rate of hospital stay.

REFERENCES

1. American Cancer Society. Cancer facts and figures 2005. Atlanta, Georgia: American Cancer Society, 2005.

2. Registro Histopatológico de Neoplasias Malignas/DGE/SSA/2000.

3. Stanford JL, Stephenson RA, Coyle LM, et al. Prostate cancer trends 1973-1995. Bethesda, Maryland: SEER Program, National Cancer Institute. National Institutes of Health publication 1991;pp:99-4543.

4. Talcott JA, Rieker P, Propert KJ, Clark JA, Wishnow KI, Loughlin KR, et al. Patient-reported impotence and incontinence after nerve-sparing radical prostatectomy. J Natl Cancer Inst 1997;89:1117.

5. Roehl KA, Han M, Ramos CG, Antenor JAV, Catalona WJ. Cancer progression and survival rates following anatomical radical retropubic prostatectomy in 3,478 consecutive patients: long-term results. J Urol, 2004;172:910.

6. Begg CB, Riedel ER, Bach PB, et al. Variations in morbidity after radical prostatectomy. N Engl J Med 2002;346:1138-44.

7. Swindle P, Eastham JA, Ohori M, et al. Do margins matter? The prognostic significance of positive surgical margins in radical prostatectomy specimens. J Urol 2005;174:903-7.

8. Lu-Yao GL, Albertsen P, Warren J, Yao S-L. Effect of age and surgical approach on complications and short-term mortality after radical prostatectomy. A population-based study. Urology 1999;54:301-7.

9. Hu JC, Gold KF, Pashos CL, Mehta SS, Litwin MS. Temporal trends in radical prostatectomy complications from 1991 to 1998. J Urol 2003;169:1443-8.

10. Peters CA, Walsh PC. Blood transfussion and anesthetic practices in radical retropubic prostatectomy. J Urol 1985;134:81.

11. Predicting blood loss and transfussion requirements during radical prostatectomy: the significant negative impact of increasing Body Mass Index.